The Evidence Backing Your Recommendation

Easily Refer Your Patient Today

Redefining the EECP® Patient Experience

Flow Therapy is advancing the EECP patient experience by pairing treatments with comprehensive education for chronic conditions including medication reconciliation.

Patient Types Who Can Benefit from Flow Therapy

Optimizing Medical Therapy

Hello, I’m Tom, I’m a 62-year-old male, and you are currently optimizing my medical therapy for my stable symptoms.

You are aware of my coronary anatomy from a previous stent, and also know that I am becoming intolerant to nitrites, and truly don’t just want another pill such as ranolazine.

Doctor, I would benefit from Flow Therapy.
Post-Cath

Hello, I’m Paul, I’m a 66-year-old diabetic male, and recently post-cath after having an abnormal stress test and clinically diagnosed angina.

You noticed a totally occluded RCA with collaterals, 1.5 cm OM1, diffused disease throughout left circ, and patent stents. I’m on aggressive medical management.

Doctor, I would like Flow Therapy.
INOCA / Microvascular

Hello, I’m Irene, I’m a 53-year-old female with metabolic syndrome managed by my PCP. I was referred to you for my exertional chest tightness and abnormal ECG/cardiac workup.

My MPI is showing a reversible defect but my left heart cath resulted in non-occlusive disease with some slow flow.

Doctor, I would benefit from Flow Therapy.
Heart Failure

Hello, I’m Frank, I’m a 79-year-old male with DM, CKD, and PAD. I am an ischemic cardiomyopathy patient with reduced LV function, and have an AICD. I’ve had a previous MI and CABGx2 years ago and now with failed grafts.

I’ve had 3 trips to the hospital last year, and I severely limit my activities to avoid dyspnea and fatigue. I am on maximal tolerated medication with a blood pressure of 100/72.

Doctor, I would like Flow Therapy.
High Risk

Hello, I’m Roberta, I’m a 75-year-old female. Over the years I’ve had multiple PCIs and a CABG. I am a diabetic, HPL, and have class 3/4 CKD.

I had an abnormal MPI showing a small area of ischemia and live a sedentary lifestyle and exercise intolerant. You have prescribed cardiac rehab previously, but I still want more benefit.

Doctor, I would benefit from Flow Therapy.

What Is Flow Therapy?

In the span of 35 hour-long EECP treatments delivered over 7 weeks, Flow Therapy makes a lasting difference in patients facing limitations associated with heart disease. Patients lie on a treatment table where compressive cuffs (similar to large blood pressure cuffs) are securely wrapped around their calves, thighs, and buttocks.

These cuffs inflate in a distal to proximal sequence during diastole, and deflate simultaneously just prior to the onset of systole. Inflation and deflation are specifically timed to the patient’s ECG to optimize therapeutic benefit.

The sequential cuff inflation creates a retrograde pressure wave that augments diastolic pressure, increasing coronary perfusion pressure and venous return to the right heart (increasing preload and cardiac output). Rapid and simultaneous cuff deflation decreases systemic vascular resistance, afterload, and cardiac workload.

An infographic of the Mechanism of Action providing mechanical force, physiologic changes, and cardiac benefit data.

Flow Therapy Facts & Outcomes

Examine Clinical Outcomes

Every year, we perform more than 40,000 EECP treatments.
88% of patients see significant improvements using validated markers.
1,000+ referring providers trust Flow Therapy centers to improve their patients.
We’ve earned a 91 Net Promoter Score (customer satisfaction).
There are 400+ clinical studies proving the efficacy and safety of EECP.
Practiced by cardiovascular leaders like Cleveland Clinic and Mayo Clinic.